Clinical Trial Update: Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the addition of Radium-223 dichloride to paclitaxel for metastatic breast cancer with bone metastases; status is ACTIVE_NOT_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Cancer with Bone Metastases

Drugs mentioned

• Taxol (paclitaxel)
• Xofigo (radium-223 dichloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING